Recent studies indicate that PTTG1 exerts its oncogenic effects through modulation of the NF-κB signaling pathway, with experimental evidence showing that PTTG1 knockdown leads to significant suppression of tumor progression, specifically through inactivation of the NF-κB pathway [91]. Here, NFKB1 is linked to neoplasm.